التفاصيل البيبلوغرافية
| العنوان: |
Sacubitril/Valsartan Does Not Change the Use and Dose of Loop Diuretics in Patients With Heart Failure With Reduced Ejection Fraction. |
| المؤلفون: |
Kido, Kazuhiko, Bianco, Christopher, Caccamo, Marco, Hashiguchi, Masayuki, Choo, Lyn Yuen, Sokos, George |
| المصدر: |
Journal of Pharmacy Practice; Jun2024, Vol. 37 Issue 3, p708-711, 4p |
| مصطلحات موضوعية: |
VENTRICULAR ejection fraction, VALSARTAN, FUROSEMIDE, RESEARCH funding, T-test (Statistics), DATA analysis, HEART failure, DIURETICS, RETROSPECTIVE studies, DESCRIPTIVE statistics, CHI-squared test, LONGITUDINAL method, MEDICAL records, ACQUISITION of data, RESEARCH, ANALYSIS of variance, DRUG utilization |
| مستخلص: |
Background: There is no standard approach for managing the use or dose of loop diuretics after initiating sacubitril/valsartan. Objective: To investigate longitudinal trends in loop diuretic therapy use and doses during the initial 6 months following sacubitril/valsartan initiation. Methods: This retrospective cohort study included adult patients who were initiated on sacubitril/valsartan in cardiology clinics. Inclusion criteria were patients diagnosed with heart failure with reduced ejection fraction (ejection fraction ≤40%) and initiated on sacubitril/valsartan in an outpatient setting. We investigated longitudinal trends in the prevalence of loop diuretic use and furosemide equivalent dose at baseline, 2 weeks, 1 month, 3 month and 6 months following sacubitril/valsartan initiation. Results: A total of 427 patients were included in the final cohort. Compared to the baseline loop diuretic use and dose, there were no significant longitudinal changes in the prevalence of loop diuretic use or the furosemide equivalent dose over the 6 months following sacubitril/valsartan initiation. The use of sacubitril/valsartan was not significantly associated with reductions in the use or dose of loop diuretics over a 6-month follow-up period. Conclusion: The use of sacubitril/valsartan did not significantly change the use or dose of loop diuretics over 6-month follow-up period. Initiation of sacubitril/valsartan may not need a pre-emptive loop diuretic dose reduction. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Pharmacy Practice is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder